The Hemophilia Inhibitor Eradication Trial

PHASE3

Phase

TERMINATED

Status

Enrollment

OTHER

Sponsor class

Stopped The INHIBIT Trials IDSMB, in a letter dated 05-18-22, recommended, given the slow enrollment, that the INHIBIT Trials be discontinued due to futility.

Conditions

Hemophilia A With Inhibitor

Interventions

DRUG: Eloctate ITI
DRUG: Emicizumab

Sponsor

Margaret Ragni

Collaborators

[object Object]